Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AVEO

AVEO Pharmaceuticals (AVEO) Stock Price, News & Analysis

AVEO Pharmaceuticals logo

About AVEO Pharmaceuticals Stock (NASDAQ:AVEO)

Advanced Chart

Key Stats

Today's Range
$14.99
$15.00
50-Day Range
$14.90
$15.00
52-Week Range
$3.06
$15.00
Volume
247,800 shs
Average Volume
601,442 shs
Market Capitalization
$521.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AVEO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AVEO Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AVEO Stock News Headlines

Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
See More Headlines

AVEO Stock Analysis - Frequently Asked Questions

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) released its quarterly earnings data on Monday, November, 8th. The biopharmaceutical company reported ($0.30) EPS for the quarter, beating the consensus estimate of ($0.36) by $0.06. The biopharmaceutical company had revenue of $15.17 million for the quarter, compared to the consensus estimate of $14.29 million. AVEO Pharmaceuticals had a negative net margin of 30.79% and a negative trailing twelve-month return on equity of 81.66%.

AVEO Pharmaceuticals's stock reverse split before market open on Thursday, February 20th 2020.The 1-10 reverse split was announced on Wednesday, February 19th 2020. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, February 19th 2020. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that AVEO Pharmaceuticals investors own include Advanced Micro Devices (AMD), Micron Technology (MU), OPKO Health (OPK), Alibaba Group (BABA), Meta Platforms (META), Exelixis (EXEL) and NVIDIA (NVDA).

Company Calendar

Last Earnings
11/08/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:AVEO
CIK
1325879
Employees
114
Year Founded
2001

Profitability

EPS (Trailing Twelve Months)
($0.84)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$53.34 million
Net Margins
-30.79%
Pretax Margin
-30.79%
Return on Equity
-81.66%
Return on Assets
-28.83%

Debt

Debt-to-Equity Ratio
0.94
Current Ratio
2.37
Quick Ratio
2.35

Sales & Book Value

Annual Sales
$42.29 million
Price / Sales
12.33
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.33 per share
Price / Book
11.28

Miscellaneous

Outstanding Shares
34,763,000
Free Float
33,619,000
Market Cap
$521.45 million
Optionable
Optionable
Beta
1.00

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:AVEO) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners